Forbius Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Bolt Biotherapeutics.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | |
Founding Date | Founding Date 2008 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Redwood City, US HQ |
Employees | Employees 15815% increase | Employees 5248% decrease |
Valuation ($) | Valuation ($) 78 m | Valuation ($) 25.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) $7.7m (FY, 2025) |
Net income | Net income ($17.4m) (FY, 2025) | Net income ($33.4m) (FY, 2025) |
Operating ⚠ | ||
Patents (US) | Patents (US) 13 (FY, 2016) | Patents (US) 1 (FY, 2020) |
Funding | ||
Total funding raised | Total funding raised $ 132.4m | Total funding raised $ 177.5m |
For sources of this data, please see the company profile
View Company Profiles
Bolt Biotherapeutics
HQ
Redwood City, US
Employees
52↓ 48% decrease
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
View company